Search Results - "Liao, Leen"

Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer by Sui, Qiaoqi, Zhang, Xi, Chen, Chao, Tang, Jinghua, Yu, Jiehai, Li, Weihao, Han, Kai, Jiang, Wu, Liao, Leen, Kong, Lingheng, Li, Yuan, Hou, Zhenlin, Zhou, Chi, Zhang, Chenzhi, Zhang, Linjie, Xiao, Binyi, Mei, Weijian, Xu, Yanbo, Qin, Jiayi, Zheng, Jian, Pan, Zhizhong, Ding, Pei-Rong

“…Inflammation is a common medical complication in colorectal cancer (CRC) patients, which plays significant roles in tumor progression and immunosuppression…”
Get full text

Application of iron/barium ferrite/carbon-coated iron nanocrystal composites in transcatheter arterial chemoembolization of hepatocellular carcinoma by Zhao, Peng, Zhao, Juanjuan, Deng, Yunfei, Zeng, Guoxun, Jiang, Yizhou, Liao, Leen, Zhang, Shangshang, Tao, Qiang, Liu, Zonghao, Tang, Xiang, Tu, Xinyue, Jiang, Lingmin, Zhang, Haiyan, Zheng, Yun

“…Fe/BaFe12O19/CCINs nanocomposites for the treatment of liver cancer with the triple effects of chemosensitization, embolization, and thermal ablation under…”
Get full text

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study by Liao, Leen, Tang, Jinghua, Hong, Zhigang, Jiang, Wu, Li, Yuan, Kong, Lingheng, Han, Kai, Hou, Zhenlin, Zhang, Chenzhi, Zhou, Chi, Zhang, Linjie, Sui, Qiaoqi, Xiao, Binyi, Mei, Weijian, Yu, Jiehai, Yang, Wanjun, Pan, Zhizhong, Ding, Pei-Rong

“…For high-risk stageIImismatch repair deficient (dMMR) colon cancers, the benefit of adjuvant chemotherapy remains debatable. The principal aim of this study…”
Get full text

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases by Liao, Leen, Sun, Hui, He, Jiahua, Liu, Yujun, Pan, Zhizhong, Wu, Xiaojun, Fan, Wenhua, Peng, Jianhong, Li, Cong

“…Abstract Background The pathological tumor burden score (TBS) has been proven to be a better risk stratification tool for liver metastasis of colorectal cancer…”
Get full text

Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer by Sui, Qiaoqi, Liu, Dingxin, Jiang, Wu, Tang, Jinghua, Kong, Lingheng, Han, Kai, Liao, Leen, Li, Yuan, Ou, Qingjian, Xiao, Binyi, Liu, Guochen, Ling, Yihong, Chen, Jiewei, Liu, Zexian, Zuo, Zhixiang, Pan, Zhizhong, Zhou, Penghui, Zheng, Jian, Ding, Pei-Rong

“…BackgroundDickkopf 1 (DKK1) is associated with tumor progression. However, whether DKK1 influences the tumor response to programmed cell death protein 1 (PD-1)…”
Get full text

A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions by Li, Yuan, Li, Bin, Jiang, Rou, Liao, Leen, Zheng, Chunting, Yuan, Jie, Zeng, Liuhong, Hu, Kunling, Zhang, Yuyu, Mei, Weijian, Hong, Zhigang, Xiao, Binyi, Kong, Lingheng, Han, Kai, Tang, Jinghua, Jiang, Wu, Pan, Zhizhong, Zhang, Shenyan, Ding, Peirong

“…Abstract Background Colorectal cancer (CRC) is one of the most common malignancies, and early detection plays a crucial role in enhancing curative outcomes…”
Get full text

A novel circumferential continuous reinforcing suture for anastomosis after laparoscopic resection for rectal cancer and sigmoid cancer: a retrospective case-controlled study by Peng, Jianhong, Zhang, Weili, Zhou, Chi, Liao, Leen, Zhang, Linjie, Fan, Wenhua, Pan, Zhizhong, Lu, Zhenhai, Lin, Junzhong

“…Introduction This study aimed to investigate the effectiveness of a novel method for anastomosis reinforcement to minimize the occurrence of anastomotic…”
Get full text

Safety and effectiveness of subtotal pelvic peritonectomy for patients with colorectal cancer with limited peritoneal metastasis in pelvic cavity by Liao, Leen, Tang, Jinghua, Xiao, Binyi, Jiang, Wu, Han, Kai, Kong, Ling-Heng, Yu, Jiehai, Pan, Zhi-Zhong, Ding, Pei-Rong

“…e15587 Background: Cytoreductive surgery with extensive visceral resection and peritonectomy has shown long-term survival benefits for colorectal cancer (CRC)…”
Get full text

B2M and JAK1/2–mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy by Zhang, Chenzhi, Li, Dandan, Xiao, Binyi, Zhou, Chi, Jiang, Wu, Tang, Jinghua, Li, Yuan, Zhang, Rongxin, Han, Kai, Hou, Zhenlin, Zhang, Linjie, Sui, Qiaoqi, Liao, Leen, Pan, Zhizhong, Zhang, Xiaoshi, Ding, Peirong

“…β2-microglobulin (B2M) and Janus kinases 1 and 2 (JAK1/2) mutations have been suggested as genetic mechanisms of immune evasion for anti–programmed cell death…”
Get full text

Efficacy of PD-1 inhibitors for colorectal cancer and polyps in patients with Lynch syndrome by Yu, Jiehai, Xiao, Binyi, Tang, Jinghua, Li, Dandan, Wang, Fang, Ding, Ya, Han, Kai, Kong, Ling-Heng, Ling, Yi-hong, Mei, Wei-Jian, Hong, Zhigang, Liao, Leen, Yang, Wanjun, Pan, Zhi-Zhong, Zhang, Xiao-Shi, Jiang, Wu, Ding, Pei-Rong

“…e15521 Background: Programmed death-1 (PD-1) inhibitor is effective for colorectal cancer (CRC) with deficient mismatch repair (dMMR) or high microsatellite…”
Get full text

MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases by He, Jiahua, Li, Weihao, Wang, Jiayu, Wu, Xiaojun, Zhang, Weili, Lin, Junzhong, Xiao, Binyi, Yu, Long, Liao, Leen, Wang, Song, Wang, Weifeng, Lin, Yuguang, Hong, Xuanlin, Xing, Yue, Pan, Zhizhong, Peng, Jianhong

“…Monocarboxylate transporter 4 (MCT4) is a novel biomarker related to the level of immune cell infiltration, but its impact on tumor immune microenvironment…”
Get full text

B2M and JAK1/2–mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy by Zhang, Chenzhi, Li, Dandan, Xiao, Binyi, Zhou, Chi, Jiang, Wu, Tang, Jinghua, Li, Yuan, Zhang, Rongxin, Han, Kai, Hou, Zhenlin, Zhang, Linjie, Sui, Qiaoqi, Liao, Leen, Pan, Zhizhong, Zhang, Xiaoshi, Ding, Peirong

“…β2-microglobulin (B2M) and Janus kinases 1 and 2 (JAK1/2) mutations have been suggested as genetic mechanisms of immune evasion for anti–programmed cell death…”
Get full text

DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer by Li, Yuan, Liao, Leen, Kong, Lingheng, Jiang, Wu, Tang, Jinghua, Han, Kai, Hou, Zhenlin, Zhang, Chenzhi, Zhou, Chi, Zhang, Linjie, Sui, Qiaoqi, Xiao, Binyi, Mei, Weijian, Xu, Yanbo, Yu, Jiehai, Hong, Zhigang, Pan, Zhizhong, Ding, Peirong

“…Background For clinically low-risk stage III colorectal cancer, the decision on cycles of adjuvant chemotherapy after surgery is disputed. The present study…”
Get full text

Apatinib versus sorafenib in patients with advanced hepatocellular carcinoma: a preliminary study by He, Wei, Liao, Leen, Hu, Dandan, Li, Binkui, Wang, Chenwei, Qiu, Jiliang, Liao, Yadi, Liu, Wenwu, Yang, Zhiwen, Zhang, Yuanping, Yuan, Yichuan, Li, Kai, Yuan, Yunfei, Zheng, Yun

“…Apatinib, a selective inhibitor of vascular endothelial growth factor receptor 2 (VEGFR 2), has exhibited modest antitumor efficacy in hepatocellular carcinoma…”
Get full text